ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest medtech news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks medtech across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
French startup HighLife raised over $90 million (about €80 million) to commercialize its catheter-based mitral valve replacement in Europe and fund clinical trials in the United States. The round was led by Sofinnova Partners, Andera Partners, Supernova Invest and Mérieux Equity Partners. HighLife obtained CE marking in January and for its Clarity valve in July.
Summaries by ByteBrief